scholarly journals Comparing Syndromic Data to Discharge Data to Measure Opioid Overdose Emergency Department Visits

2019 ◽  
Vol 11 (1) ◽  
Author(s):  
Emilia S. Pasalic ◽  
Alana Marie Vivolo-Kantor ◽  
Pedro Martinez

ObjectiveEpidemiologists will understand the differences between syndromic and discharge emergency department data sources, the strengths and limitations of each data source, and how each of these different emergency department data sources can be best applied to inform a public health response to the opioid overdose epidemic.IntroductionTimely and accurate measurement of overdose morbidity using emergency department (ED) data is necessary to inform an effective public health response given the dynamic nature of opioid overdose epidemic in the United States. However, from jurisdiction to jurisdiction, differing sources and types of ED data vary in their quality and comprehensiveness. Many jurisdictions collect timely emergency department data through syndromic surveillance (SyS) systems, while others may have access to more complete, but slower emergency department discharge datasets. State and local epidemiologists must make decisions regarding which datasets to use and how to best operationalize, interpret, and present overdose morbidity using ED data. These choices may affect the number, timeliness, and accuracy of the cases identified.MethodsCDC partnered with 45 states and the District of Columbia to combat the worsening opioid overdose epidemic through three cooperative agreements: Prevention for States (PFS), Data Driven Prevention Initiative (DDPI), and Enhanced State Opioid Overdose Surveillance (ESOOS). To support funded jurisdictions in monitoring non-fatal opioid overdoses, CDC developed two different sets of indicator guidance for measuring non-fatal opioid overdoses using ED data, with each focusing on different ED data sources (SyS and discharge). We report on the following attributes for each type of ED data source1,2: 1) timeliness; 2) data quality (e.g., percent completeness by field); 3) validity; and 4) representativeness (e.g., percent of facilities included).ResultsWhen comparing timeliness across data sources, SyS data has clear advantages, with many jurisdictions receiving data within 24 hours of an event. For discharge data, timeliness is more variable with some jurisdictions receiving data within weeks while others wait over 1.5 years before receiving a complete discharge dataset. Data quality and completeness tends to be stronger in discharge datasets as facilities are required to submit complete discharge records with valid ICD-10-CM codes in order to be reimbursed by payers. By contrast, for SyS data systems, participating facilities may not consistently submit data for all possible fields, including diagnosis. Validity is dependent on the data source as well as the case definition or syndrome definition used; with this in mind, SyS data overdose indicators are designed to have high sensitivity, with less attention to specificity. Discharge data overdose indicators are designed to have a high positive predictive value, while sensitivity and specificity are both important considerations. Discharge datasets often include records for 100% of ED visits from all nonfederal, acute care-affiliated facilities in a state included. By contrast, representativeness of facilities in SyS data systems varies widely across states with some states having less than 50% of facilities reporting.ConclusionsCDC funded partners share overdose morbidity data with CDC using either ED SyS data, ED discharge data, or both. CDC indicator guidance for ED discharge data is designed for states to track changes in health outcomes over time for descriptive, performance monitoring, and evaluation purposes and to create rates that are more comparable across injury category, time, and place. Considering these objectives, CDC placed a higher priority on data quality, validity (i.e., positive predictive value), and representativeness, all of which are stronger attributes of discharge data. CDC’s indicator guidance for ED SyS data is designed for states to rapidly identify changes in nonfatal overdoses and to identify areas within a particular state that are experiencing rapid change in the frequency or types of overdose events. When considering these needs, CDC prioritized timeliness and validity in terms of sensitivity, both of which are stronger attributes of SyS data. SyS and discharge ED data each lend themselves to different informational applications and interpretations based on the strengths and limitations of each dataset. An effective, informed public health response to the opioid overdose epidemic requires continued investment in public health surveillance infrastructure, careful consideration of the needs of the data user, and transparency regarding the unique strengths and limitations of each dataset.References1. Pencheon, D. (2006). Oxford handbook of public health practice. 2nd ed. Oxford: Oxford University Press.2. Centers for Disease Control and Prevention (CDC) Evaluation Working Group on Public Health Surveillance Systems for Early Detection of Outbreaks. (May 7, 2004). Framework for Evaluating Public Health Surveillance Systems for Early Detection of Outbreaks. MMWR. Morbidity and Mortality Weekly Reports. Retrieved from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5305a1.htm 

One Health ◽  
2021 ◽  
pp. 100338
Author(s):  
Tatiana Petukhova ◽  
David L. Pearl ◽  
Maria Spinato ◽  
Jim Fairles ◽  
Murray Hazlett ◽  
...  

2020 ◽  
Author(s):  
Romana Haneef ◽  
Marie Delnord ◽  
Michel Vernay ◽  
Emmanuelle Bauchet ◽  
Rita Gaidelyte ◽  
...  

Abstract Background The availability of data generated from different sources is increasing with the possibility to link these data sources together. However, linked administrative data can be complex to use and may require advanced expertise and skills in statistical analysis. The main objectives of this study were to describe the current use of data linkage at the individual level and the artificial intelligence (AI) in routine public health activities, and to identify the related health outcome and intervention indicators and determinants of health for non-communicable diseases. Method We performed a survey across European countries to explore the current practices applied by national institutes of public health and health information and statistics for innovative use of data sources (i.e., the use of data linkage and/or the AI). Results The use of data linkage and the AI at national institutes of public health and health information and statistics in Europe varies. The majority of European countries use data linkage in routine by applying a deterministic method or a combination of two types of linkages (i.e., deterministic & probabilistic) for public health surveillance and research purposes. The use of AI to estimate health indicators is not frequent at national institutes of public health and health information and statistics. Using linked data, 46 health outcome indicators related to seven health conditions, 34 indicators related to determinants and 23 to health interventions were estimated in routine. Complex data regulation laws, lack of human resources, skills and problems with data governance, were reported by European countries as obstacles to link different data sources in routine for public health surveillance and research. Conclusions Our results highlight that the majority of European countries have integrated data linkage in routine public health activities but a few use the AI. A sustainable national health information system and a robust data governance framework allowing to link different data sources are essential to support evidence-informed health policy development process. Building analytical capacity and awareness of the added value of data linkage in national institutes is necessary for improving the utilization of linked data in order to improve the monitoring of public health activities.


2014 ◽  
Vol 11 ◽  
Author(s):  
Debbie Travers ◽  
Kristen Hassmiller Lich ◽  
Steven J. Lippmann ◽  
Morris Weinberger ◽  
Karin B. Yeatts ◽  
...  

2019 ◽  
Vol 134 (5) ◽  
pp. 537-541
Author(s):  
Julia Brennan ◽  
Caleb Wiedeman ◽  
John R. Dunn ◽  
William Schaffner ◽  
Timothy F. Jones

Objectives: Between 2003 and 2013, the rate of neonatal abstinence syndrome (NAS)—a postnatal drug withdrawal syndrome—in Tennessee increased approximately 10-fold. NAS surveillance is relatively new, and underestimation associated with surveillance has not been described. We compared data from the Tennessee NAS public health surveillance system (TNSS) with a second source of NAS data, hospital discharge data system (HDDS), and estimated the true number of infants with NAS using capture-recapture methods. Methods: We obtained NAS data on cases of NAS among Tennessee infants from TNSS and HDDS from January 1, 2013, through December 31, 2016. We matched cases of NAS identified in TNSS to cases identified in HDDS. We estimated the true number of infants with NAS by using the Lincoln-Peterson estimator capture-recapture methodology. Results: During the study period, 4070 infants with NAS were reported to TNSS, and 5321 infants with NAS were identified in HDDS; 2757 were in both data sets. Using capture-recapture methods, the total estimated number of infants with NAS during the study period was 7855 (annual mean = 1972; estimated range = 1531-2427), which was 93% more than in TNSS and 48% more than in HDDS. Drugs used for the medication-assisted treatment of substance use disorder were the most commonly reported substances associated with NAS (n = 2389, 59%). Conclusions: TNSS underestimated the total burden of NAS based on the capture-recapture estimate. Case-based public health surveillance is important for monitoring the burden of and risk factors for NAS and helping guide public health interventions.


2021 ◽  
Vol 5 (1) ◽  
pp. e000967
Author(s):  
Dhurgshaarna Shanmugavadivel ◽  
Jo-Fen Liu ◽  
Colin Gilhooley ◽  
Loai Elsaadany ◽  
Damian Wood

BackgroundThe SARS-CoV-2 pandemic and initial public health response led to significant changes in health service delivery, access and utilisation. However, SARS-CoV-2 illness burden in children and young people (CYP) is low. To inform effective child public health interventions, we aimed to compare patterns of paediatric emergency department presentation during the initial pandemic response with a previous non-pandemic period.MethodsRetrospective review of attendances (0–18 years) over the initial pandemic (2 March 2020–3 May 2020) compared with 2019. Outcome measures included number of attendances, referral source, presenting complaint, discharge diagnosis and disposal. Descriptive statistics with subgroup analysis by age/sex/ethnicity and pandemic time periods (pre-lockdown, lockdown weeks 1–3 and lockdown weeks 4–6) was performed.Results4417 attendances (57% illness and 43% injuries) occurred, compared with 8813 (57% illness and 43% injuries), a reduction of 50%, maximal in lockdown week 2 (−73%). Ranking of top three illness presentations changed across the pandemic weeks. Breathing difficulty dropped from first (300, 25%) to second (117, 21%) to third (59, 11%) (p<0.001). Abdominal pain rose from the third pre-lockdown (87, 7%) and lockdown weeks 1–3 (37, 7%) to second in weeks 4–6 (62, 12%; p=0.004). Fever ranked second (235, 19%) in pre-lockdown and first in weeks 1–3 (134, 24%) and weeks 4–6 (94, 18%; p=0.035).ConclusionsDespite a 50% reduction, there was no significant change in acuity of illness. Rank of illness presentations changed, with abdominal pain ranking second and fever first, an important change from previous, which should prompt further research into causes. CYP-specific public health messaging and guidance for primary care are required in this second wave to ensure access to appropriate emergency services.


Sign in / Sign up

Export Citation Format

Share Document